396 related articles for article (PubMed ID: 29256155)
1. Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma.
Lee J; Kang SH; Noh OK; Chun M; Oh YT; Kim BW; Kim SW
Clin Transl Oncol; 2018 Aug; 20(8):1011-1017. PubMed ID: 29256155
[TBL] [Abstract][Full Text] [Related]
2. Impact of adjuvant radiation therapy for microscopic residual tumor after resection of extrahepatic bile duct cancer.
Matsuda T; Fujita H; Harada N; Kunimoto Y; Tanaka T; Kimura T; Kitaoka H; Asano E; Hosono M; Hayashi T; Ogino K
Am J Clin Oncol; 2013 Oct; 36(5):461-5. PubMed ID: 22706178
[TBL] [Abstract][Full Text] [Related]
3. Role of adjuvant (chemo)radiotherapy for resected extrahepatic cholangiocarcinoma: a meta-analysis.
Shi XQ; Zhang JY; Tian H; Tang LN; Li AL
J Zhejiang Univ Sci B; 2020 Jul; 21(7):549-559. PubMed ID: 32633109
[TBL] [Abstract][Full Text] [Related]
4. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
[TBL] [Abstract][Full Text] [Related]
5. Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma.
Dover LL; Oster RA; McDonald AM; DuBay DA; Wang TN; Jacob R
HPB (Oxford); 2016 Oct; 18(10):843-850. PubMed ID: 27542590
[TBL] [Abstract][Full Text] [Related]
6. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Chemotherapy and Radiation Therapy is Associated with Improved Survival for Patients with Extrahepatic Cholangiocarcinoma.
Hoehn RS; Wima K; Ertel AE; Meier A; Ahmad SA; Shah SA; Abbott DE
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1133-9. PubMed ID: 25976862
[TBL] [Abstract][Full Text] [Related]
8. Role of adjuvant radiotherapy in extrahepatic bile duct cancer: A multicenter retrospective study (Korean Radiation Oncology Group 18-14).
Kim K; Yu JI; Jung W; Kim TH; Seong J; Kim WC; Choi JH; Park Y; Jeong BK; Kim BH; Kim TG; Kim JH; Park HJ; Shin HS; Im JH; Heo JS; Park JO; Jang JY; Oh DY; Woo SM; Lee WJ; Chie EK
Eur J Cancer; 2021 Nov; 157():31-39. PubMed ID: 34474218
[TBL] [Abstract][Full Text] [Related]
9. The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma.
Palloni A; Bisello S; Maggio I; Massucci M; Galuppi A; Di Federico A; Rizzo A; Ricci AD; Siepe G; Morganti AG; Brandi G; Frega G
Curr Oncol; 2023 May; 30(5):4754-4766. PubMed ID: 37232816
[TBL] [Abstract][Full Text] [Related]
10. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
Ben-David MA; Griffith KA; Abu-Isa E; Lawrence TS; Knol J; Zalupski M; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):772-9. PubMed ID: 17011452
[TBL] [Abstract][Full Text] [Related]
11. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas.
Kim YS; Oh SY; Go SI; Kang JH; Park I; Song HN; Ji JH; Hwang IG; Jang JS
Cancer Chemother Pharmacol; 2017 Jan; 79(1):99-106. PubMed ID: 27928598
[TBL] [Abstract][Full Text] [Related]
12. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
[TBL] [Abstract][Full Text] [Related]
13. Effect of Margin Status on Survival After Resection of Hilar Cholangiocarcinoma in the Modern Era of Adjuvant Therapies.
Watson MD; Baimas-George MR; Passeri MJ; Sulzer JK; Baker EH; Ocuin LM; Martinie JB; Iannitti DA; Vrochides D
Am Surg; 2021 Sep; 87(9):1496-1503. PubMed ID: 33345594
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma.
Zhang XF; Squires MH; Bagante F; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Weiss M; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
Ann Surg Oncol; 2018 May; 25(5):1140-1149. PubMed ID: 29470820
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer.
Kim SW; Noh OK; Kim JH; Chun M; Oh YT; Kang SY; Lee HW; Park RW; Yoon D
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1161-1167. PubMed ID: 28447209
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma.
Spolverato G; Yakoob MY; Kim Y; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Marsh JW; Pawlik TM
Ann Surg Oncol; 2015 Nov; 22(12):4020-8. PubMed ID: 25762481
[TBL] [Abstract][Full Text] [Related]
18. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
[TBL] [Abstract][Full Text] [Related]
19. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
[TBL] [Abstract][Full Text] [Related]
20. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone.
Borghero Y; Crane CH; Szklaruk J; Oyarzo M; Curley S; Pisters PW; Evans D; Abdalla EK; Thomas MB; Das P; Wistuba II; Krishnan S; Vauthey JN
Ann Surg Oncol; 2008 Nov; 15(11):3147-56. PubMed ID: 18754070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]